Savant Capital’s Endologix Inc ELGX Stock Holding History

Savant Capital’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,258	Closed	-$9K	–	288
2018 Q4	$9K	Buy	+1,258	New	+$14K	﹤0.01%	261

Other funds holding ELGX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Stephens Inc Little Rock, Arkansas $7.99B AUM 21.6% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Savant Capital's ELGX Position: Q1 2019 in Review

Savant Capital sold out of Endologix Inc (ELGX) in Q1 2019, closing a stake of 1,258 shares — an estimated $9K sold.

Savant Capital first reported a position in ELGX in Q4 2018 and held it in 1 quarter. The position peaked at $9K in Q4 2018. 63 funds tracked by Wall St. Rank hold ELGX as of Q1 2019.

Savant Capital reported no remaining Endologix Inc position as of Q1 2019 after selling out during the quarter.
Savant Capital sold 1,258 Endologix Inc shares in Q1 2019, an estimated $9K.
Savant Capital first reported a position in Endologix Inc in Q4 2018 and held it in 1 quarter.
Savant Capital's Endologix Inc position peaked at $9K in Q4 2018.
63 funds tracked by Wall St. Rank held Endologix Inc as of Q1 2019.

Based on Savant Capital's 13F filing for Q1 2019, filed 2 May 2019.